On Thursday, May 3, 2018, I defended my doctoral dissertation research in The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington and became a doctor.
Introducing the context for my research during the one-hour lecture.My generous mother, Lisa McLoughlin, prepared a delicious spread of food that was enjoyed before and after the talk. The menu included beet tartare on endive leaves, hard and soft cheeses, grand central bakery baguettes, roasted almond date spread, prosciutto, salami, olives, vegetable cups with green goddess dressing, grapes, strawberries, spindrift sparkling waters, fresh kettle corn, cream puffs, truffles, and homemade nordie bars.
Mathematical Models
This schematic represents the deterministic dynamic compartmental model. The boxes represent disease-stage compartments of men who have sex with men and the arrows represent transitions between compartments. Individuals enter into the unvaccinated population and may die or exit the population at various disease stages. Not represented in the diagram is stratification by age group (15-24, 24-44, and 45-64 years), risk group (low and high), and sexual role (anal insertive, receptive, or versatile). S, susceptible; SP, susceptible using PrEP; SPV, susceptible using PrEP and partial protection with HIV vaccine; SV, susceptible with partial protection from HIV vaccine; I, infected and unaware; D, diagnosed; E, engaged in care but not using ART; U, engaged in care and using ART but not yet virally suppressed; T, engaged in care and virally suppressed on ART.
Interrogation
Responding to difficult questions from committee members during the private interrogation period.
The priviledge to ask and answer my own scientific questions was only possible because of the dedicated professors and mentors who gifted me with hours, sweat, code, advice, dark chocolate, homework, corrections, inspiration, and affirmation. I will be forever grateful.
Dissertation Committee members (left to right): Jim Kublin, Josh Carlson, Lou Garrison, me, Ruanne Barnabas, and Dobromir Dimitrov.
Celebration
I celebrated later that evening with a massive delivery of Chinese food from Snappy Dragon that was enjoyed with a glass of Veuve Clicquot while lounging on my living room floor and surrounded by my closest friends and our dozen children.
Beautiful view from the room where I defended my dissertation in the WRF Data Science Studio on the top floor of the Physics and Astronomy building at the University of Washington.Graduation portrait credit to Rahil Jain, PhD.
Kangho Suh wrote an excellent article on the use of instrumental variables in healthcare. I agree this technique strengthens causal inference for analyses of observational data. This is even more important when a randomized controlled trial is not feasible or ethical. SaveSave
There is little prior evidence of effective interventions to improve viral suppression, despite this being a critical step in the HIV care continuum as described in the National HIV/AIDS Strategy for the United States.
Pulled from the Infectious Economics archives, these articles provide recommendations for the design and development of robust mathematical models of COVID-19 epidemiology and economics to reduce uncertainty in decision-making and inform evidence-based public policy. Associations are easy; valid causal inference is hard If we want to be honest in evaluating the winners and losers in…
On Tuesday, April 17, the journal Nature Scientific Reports published our paper “Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling study.” A few hours later, a reporter from BBC World Service reached out to discuss the the results of our study. Live Interview You can listen to this clip with…
Lab coats are being ironed, promo stickers wrapped around candy bars, and strangers pulled off the street to help with utility testing. It’s time for the Business Plan Competition.
New paper in Vaccine shows staggered age targeting and the durability of protection will be key to strategic and efficient vaccination in South Africa. When an HIV vaccine is ready to launch in South Africa, an efficient implementation strategy needs to be ready. I worked with 3 women scientists in South Africa, 3 academic men…
